Suppr超能文献

具有中间型(肝细胞-胆管细胞)表型的原发性肝癌。

Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.

作者信息

Kim Haeryoung, Park Chanil, Han Kwang-Hyup, Choi Jinsub, Kim Young Bae, Kim Ja Kyung, Park Young Nyun

机构信息

Department of Pathology and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

J Hepatol. 2004 Feb;40(2):298-304. doi: 10.1016/j.jhep.2003.10.023.

Abstract

BACKGROUND/AIMS: Recent evidence of hepatic progenitor cells with the bipotential to differentiate into hepatocytes and cholangiocytes gives rise to the suggestion that primary hepatic carcinomas with features intermediate between hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) may originate from hepatic progenitor cells.

METHODS

Fifty-four cases of primary liver carcinomas were selected and an immunohistochemical analysis was performed using hepatocytic markers (alpha-fetoprotein, hepatocyte), cholangiocytic markers (carcinoembryonic antigen, cytokeratin 19) and progenitor cell marker (c-kit).

RESULTS

Thirteen cases designated 'intermediate' carcinomas demonstrated strands/trabeculae of small, uniform, round-to-oval cells with scanty cytoplasm and hyperchromatic nuclei embedded within a thick desmoplastic stroma. Six were designated transitional type combined hepatocellular-cholangiocarcinoma (CHC). Ten were named HCC small cell type, demonstrating similar features to typical HCC, but composed of smaller cells. Simultaneous expression of hepatocytic and cholangiocytic markers was demonstrated in 8/13 (61.5%), 4/6 (66.7%), and 3/10 (30%) cases of intermediate carcinomas, transitional CHCs, and HCC small cell type, respectively, and c-kit expression was noted in 10/13 (76.9%), 4/6 (66.7%) and 7/10 (70%) cases, in the same order.

CONCLUSIONS

Intermediate carcinoma may be a distinct type of primary liver carcinoma, morphologically and phenotypically intermediate between HCC and CC, which originates from transformed hepatic progenitor cells.

摘要

背景/目的:近期有证据表明肝祖细胞具有分化为肝细胞和胆管细胞的双潜能,这提示具有肝细胞癌(HCC)和胆管癌(CC)之间中间特征的原发性肝癌可能起源于肝祖细胞。

方法

选取54例原发性肝癌病例,采用肝细胞标志物(甲胎蛋白、肝细胞)、胆管细胞标志物(癌胚抗原、细胞角蛋白19)和祖细胞标志物(c-kit)进行免疫组化分析。

结果

13例被指定为“中间型”癌,表现为小的、形态一致、圆形至椭圆形细胞形成的条索/小梁,细胞质稀少,核深染,包埋于厚的促纤维组织增生性间质中。6例被指定为移行型肝细胞-胆管癌(CHC)。10例被命名为HCC小细胞型,表现出与典型HCC相似的特征,但由较小的细胞组成。中间型癌、移行型CHC和HCC小细胞型病例中,分别有8/13(61.5%)、4/6(66.7%)和3/10(30%)同时表达肝细胞和胆管细胞标志物,c-kit表达分别见于10/13(76.9%)、4/6(66.7%)和7/10(70%)的病例,顺序相同。

结论

中间型癌可能是一种独特的原发性肝癌类型,在形态学和表型上介于HCC和CC之间,起源于转化的肝祖细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验